Residual neuromuscular blockades. Clinical consequences, frequency and avoidance strategies;Neuromuskuläre restblockaden. Klinische konsequenzen, häufigkeit und vermeidungsstrategien

Anaesthesist

Volumn 55, Issue 1, 2006, Pages 7-16

  Fuchs Buder, T ^a   Eikermann, M ^b  

^a CHU NANCY BRABOIS   (France)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Acceleromyography; Muscle relaxants; Neuromuscular blockade; Residual effects; Train of four ratio

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; MUSCLE RELAXANT AGENT; SEDATIVE AGENT;

ACCELEROMETRY; ANESTHESIST; ARTICLE; BREATHING REFLEX; DRUG MECHANISM; FORCED EXPIRATORY VOLUME; HUMAN; LUNG COMPLICATION; NEUROMUSCULAR BLOCKING; PATIENT MONITORING; PHARYNX DISEASE; POSTOPERATIVE PERIOD; RISK ASSESSMENT; SIDE EFFECT; UPPER RESPIRATORY TRACT OBSTRUCTION;

AIRWAY OBSTRUCTION; ANOXIA; ELECTRIC STIMULATION; HUMANS; LUNG DISEASES; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR BLOCKING AGENTS; PHARYNGEAL DISEASES; POSTOPERATIVE COMPLICATIONS;

EID: 31644438949     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-005-0959-2     Document Type: Article

References (51)

1. Ali HH, Savarese JJ (1976) Monitoring of neuromuscular function. Anesthesiology 45:216-249
2. Ali HH, Wilson RS, Savarese JJ (1975) The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth 47:570-574
3. American Thoracic Society (1995) Standardisation of spirometry, 1994 update. Am J Respir Crit Care Med 152:1107-1136
4. Arbous MS, Meursing AEE, Kleef JW van et al. (2005) Impact on anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 102:257-268
5. Arora NS, Gal TJ (1981) Cough dynamics during progressive expiratory muscle weakness in healthy curarized subjects. J Appl Physiol 51:494-498
6. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M (2000) Residual curarization in the recovery room after vecuronium. Br J Anaesth 84:394-395
7. Baraka A (1975) Potentiation of suxamethonium blockade by neostigmine in patients with atypical cholinesterase. Br J Anaesth 47:416-418
8. Begin P, Mathieu J, Almirall J, Grassino A (1977) Relationship between chronic hypercapnia and respiratory muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 156:133-139
9. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbäk J, Skovgaard LT, Krintel JJ (1997) Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 41:1095-1103
10. Bevan DR, Smith CE, Donati F (1988) Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 69:272-276
11. Bevan DR, Donati F, Kopman AF (1992) Reversal of neuromuscular blockade. Anesthesiology 77:785-805
12. Blobner M, Mann R (2001) Anästhesie bei Patienten mit Myasthenia gravis. Anaesthesist 50:484-493
13. Brodie BC (1811) Experiments and observations on the different modes in which death is produced by certain vegetable poisons. Philos Trans R Soc 101:194-195
14. Bye PT, Ellis ER, Issa FG, Donnelly PM, Sullivan CE (1990) Respiratory failure and sleep in neuromuscular disease. Thorax 45:241-247
15. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T (2004) Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology 100:1119-1124
16. Debaene B, Plaud B, Dilly MP, Donati F (2003) Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 98:1042-1048
17. Eikermann M, Groeben H, Hüsing J, Peters J (2003) Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 98:1333-1337
18. Eikermann M, Gröben H, Bünten B, Peters J (2005) Fade of pulmonary function during residual neuromuscular blockade. Chest 127:1703-1709
19. Eikermann M, Hasselmann C, Beiderlinden M, Peters J (2005) Force, fatigue, and contractile behaviour of skeletal muscle after clinical recovery from neuromuscular blockade. Anesthesiology 103:A1125
20. Eikermann M, Vogt FM, Dastgerdi MV, Herbstreit F, Peters J (2005) Inspiratory upper airway obstruction during partial neuromuscular blockade. Anesthesiology 103:A1114
21. Eikermann M, Grote T, Blobner M, Rex C, Groeben H, Peters J (2006) Postoperative upper airway obstruction after recovery of the TOF-ratio of the adductor pollicis muscle from neuromuscular blockade. Anesth Analg (in press)
22. Eriksson LI (1996) Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Scand 40:520-523
23. Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O, Kuylenstierna R (1997) Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 87:1035-1043
24. Frank SM, Fleisher LA, Olson KF et al. (1995) Multivariate determinants of early postoperative oxygen consumption in elderly patients. Effects of shivering, body temperature, and gender. Anesthesiology 83:241-249
25. Fuchs-Buder T, Mencke T (2001) Neuromuskuläres Monitoring. Anaesthesist 50:129-138
26. Fuchs-Buder T, Mencke T (2001) Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting). Eur J Anaesth 18 [Suppl 23]:53-59
27. Fuchs-Buder T, Tassonyi E (1996) Magnesium sulphate enhances residual neuromuscular block induced by vecuronium. Br J Anaesth 76:565-566
28. Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M (2003) Einsatz des neuromuskulären Monitorings in Deutschland. Anaesthesist 52:522-526
29. Gal TJ, Goldberg SK (1981) Relationship between respiratory muscle strength and vital capacity during partial curarization in awake subjects. Anesthesiology 54:141-147
30. 2: an example of respiratory sparing? Anesthesiology 45:22-28
31. Gijsenbergh F, Ramael S, Houwing NM, Iersel T van (2005) First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 103:695-703
32. Harper NJ, Martlew R, Strang T, Wallace M (1994) Monitoring neuromuscular block by acceleromyograph: comparison of the mini-accelerograph with the myograph. Br J Anaesth 72:411-414
33. Jonsson M, Wyon N, Lindahl SG, Fredholm BB, Eriksson LI (2004) Neuromuscular blocking agents block carotid body neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 497:173-180
34. Kleinschmidt S, Ziegeler S, Bauer C (2005) Cholinesterasehemmer: Stellenwert in Anästhesie, Intensivmedizin, Notfallmedizin und Schmerztherapie. Anaesthesist 54:791-799
35. Kopman AF, Sinha N (2003) Acceleromyography as a guide to anesthetic management: a case report. J Clin Anesth 15:145-148
36. Lee C (1975) Train-of-four quantification of competitive neuromuscular block. Anesth Analg 54:649-653
37. Meistelman C, Fuchs-Buder T (2005) Benefit/risk ratio of neuromuscular blocking agents. In: Bannister J, Mellor I (eds) ESA refresher course book 2005, pp 87-91;http://www.euroanesthesia.org/education/rc2005vienna/9RC2.pdf. Cited 14 Dec 2005
38. Meistelman C, Fuchs-Buder T, Debaene B, Plaud B (2005) Curarisation peropératoire. In: Conférénces d'actualisation. Les essentiels 2005. Elsevier, Paris, pp 403-418
39. Melissant CF, Lammers JW, Demedts M (1995) Rigid external resistances cause effort dependent maximal expiratory and inspiratory flows. Am J Respir Crit Care Med 152:1709-1712
40. Mencke T, Echternach M, Kleinschmidt S, Lux P, Barth V, Plinkert PK, Fuchs-Buder T (2003) Laryngeal morbidity and quality of tracheal intubation: a randomized, controlled trial. Anesthesiology 98:1049-1056
41. Miller RD (1976) Antagonism of neuromuscular blockade. Anesthesiology 44:318-329
42. Samet A, Capron F, Alla F, Meistelman C, Fuchs-Buder T (2005) Single acceleromyographic train-of-four, 100 hertz tetanus or double burst stimulation: which test performs better to detect residual paralysis. Anesthesiology 1002:51-56
43. Savarese JJ, Caldwell JE, Lien CA, Miller RD (2000) Pharmacology of muscle relaxants and their antagonists. In: Miller RD (ed) Anesthesia, 5th edn. Churchill Livingstone, Philadelphia, pp 412-490
44. Schlaich N, Fuchs-Buder T (2001) Neuromuskuläres Monitoring: Die Wahl des Stimulationsmusters. Anaesthesist 49 [Suppl 1]:11-13
45. Sparr HJ (2002) Cyclodextrine: Ein neues Konzept zur Antagonisierung von Muskelrelaxanzien. Anaesthesist 51:929-930
46. Sparr HJ, Beaufort TM, Fuchs-Buder T (2001) Newer neuromuscular blocking agents: how do they compare with established agents? Drugs 61:919-942
47. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI (2000) The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 92:977-984
48. Varrato J, Siderowf A, Damiano P, Gregory S, Feinberg D, McCluskey L (2001) Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology 24:357-359
49. Viby-Mogensen J, Jensen E, Werner M, Kirkegaard-Nielsen H (1988) Measurement of acceleration: a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand 32:45-48
50. Wyon N, Joensen H, Yamamoto Y, Lindahl SG, Eriksson LI (1998) Carotid body chemoreceptor function is impaired by vecuronium during hypoxia. Anesthesiology 89:1471-1479
51. Yost CS, Maestrone E (1994) Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor. Anesth Analg 78:520-526